The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.
While the Oxford, UK-based company has focused on drug development partnerships to date, it is also keen to see uptake of genetic disease risk screening by the NHS.
The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.
The Chan Zuckerberg Initiative is leading efforts to build cloud infrastructure, scale the platform, and distribute data from the project.
The partners will integrate medical information into LunaDNA pulled from electronic health records via Medfusion's application program interfaces.
The center, launched by the National University of Ireland Galway, plans to train 115 doctoral students in genomics data science over the next seven years.
The companies will build clinical-genomic datasets to serve medical practitioners at the point of care as well as inform drug development.
At the NCI's Childhood Cancer Data Initiative Symposium, speakers emphasized measures such as data harmonization and the need for longitudinal data collection.
The software, presented at the ISMB/ECCB conference, helps researchers fill in gaps in the human epigenome thanks to 3D deep-learning techniques.
Startup healthcare analytics company Progknowse will work with hospitals and sequencing labs to build a clinical and genomic dataset.
In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.
The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.
People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.
MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.